249 related articles for article (PubMed ID: 23657678)
1. Relationship between aspirin/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation.
Park J; Shin DH; Kim BK; Her AY; Kim YH; Choi HH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1181-6. PubMed ID: 23657678
[TBL] [Abstract][Full Text] [Related]
2. Impact of cytochrome P450 2C19 loss-of-function polymorphism on intra-stent thrombi and lesion outcome after everolimus-eluting stent implantation compared to that after first-generation drug-eluting stent implantation.
Konishi A; Shinke T; Otake H; Nishio R; Sawada T; Takaya T; Nakagawa M; Osue T; Taniguchi Y; Iwasaki M; Kinutani H; Masaru K; Takahashi H; Terashita D; Shite J; Hirata K
Int J Cardiol; 2015 Jan; 179():476-83. PubMed ID: 25465810
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers.
Nishio R; Shinke T; Otake H; Nakagawa M; Inoue T; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Hiranuma N; Konishi A; Kinutani H; Kuroda M; Hirata K
Thromb Res; 2013 Nov; 132(5):558-64. PubMed ID: 24080149
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
[TBL] [Abstract][Full Text] [Related]
5. Impact of residual platelet reactivity under clopidogrel treatment for lesions and the clinical outcome after drug-eluting stent implantation in patients with hemodialysis.
Konishi A; Shinke T; Otake H; Takaya T; Osue T; Kinutani H; Kuroda M; Takahashi H; Terashita D; Hirata K
J Cardiol; 2016 Jun; 67(6):531-7. PubMed ID: 26299610
[TBL] [Abstract][Full Text] [Related]
6. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus assessed by follow-up optical coherence tomography in Chinese patients receiving clopidogrel.
Li S; Shi Y; Wang H; Zhang W; Liu J
J Thromb Thrombolysis; 2015 Jul; 40(1):88-96. PubMed ID: 25800884
[TBL] [Abstract][Full Text] [Related]
7. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
[TBL] [Abstract][Full Text] [Related]
8. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
[TBL] [Abstract][Full Text] [Related]
9. Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel.
Sawada T; Shinke T; Shite J; Honjo T; Haraguchi Y; Nishio R; Shinohara M; Toh R; Ishida T; Kawamori H; Kozuki A; Inoue T; Hariki H; Hirata K
Circ J; 2011; 75(1):99-105. PubMed ID: 21099121
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
[TBL] [Abstract][Full Text] [Related]
11. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in japanese patients receiving clopidogrel.
Nishio R; Shinke T; Otake H; Sawada T; Haraguchi Y; Shinohara M; Toh R; Ishida T; Nakagawa M; Nagoshi R; Kozuki A; Inoue T; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Hiranuma N; Konishi A; Kinutani H; Shite J; Hirata K
Circ J; 2012; 76(10):2348-55. PubMed ID: 22785462
[TBL] [Abstract][Full Text] [Related]
13. Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.
Ichikawa M; Takei Y; Hamasaki T; Kijima Y
Circ J; 2015; 79(1):85-90. PubMed ID: 25744629
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor versus clopidogrel for prevention of subclinical stent thrombosis detected by optical coherence tomography in patients with drug-eluting stent implantation-a multicenter and randomized study.
Wu X; You W; Wu Z; Wu Q; Jiang J; Yan H; Ye F; Chen S
Platelets; 2021 Apr; 32(3):404-412. PubMed ID: 32326796
[No Abstract] [Full Text] [Related]
15. Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography.
Otake H; Shite J; Ako J; Shinke T; Tanino Y; Ogasawara D; Sawada T; Miyoshi N; Kato H; Koo BK; Honda Y; Fitzgerald PJ; Hirata K
JACC Cardiovasc Interv; 2009 May; 2(5):459-66. PubMed ID: 19463471
[TBL] [Abstract][Full Text] [Related]
16. Impact of hemodialysis on local vessel healing and thrombus formation after drug-eluting stent implantation.
Konishi A; Shinke T; Otake H; Nakatani D; Nakagawa M; Inoue T; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Hiranuma N; Kinutani H; Kuroda M; Shite J; Hirata K
J Cardiol; 2014 Jul; 64(1):25-31. PubMed ID: 24377659
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
18. Mechanical abnormalities associated with first- and second-generation drug-eluting stent thrombosis analyzed by optical coherence tomography in the national PESTO French registry.
Amabile N; Trouillet C; Meneveau N; Tissot CM; Belle L; Combaret N; Range G; Pansieri M; Delaunay R; Levesque S; Lhermusier T; Derimay F; Motreff P; Caussin C; Souteyrand G
Int J Cardiol; 2017 Jan; 227():161-165. PubMed ID: 27863292
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study.
Varenhorst C; Koul S; Erlinge D; Lagerqvist B; Siegbahn A; Wallentin L; James S
Am Heart J; 2011 Aug; 162(2):363-71. PubMed ID: 21835299
[TBL] [Abstract][Full Text] [Related]
20. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.
Guagliumi G; Sirbu V; Musumeci G; Gerber R; Biondi-Zoccai G; Ikejima H; Ladich E; Lortkipanidze N; Matiashvili A; Valsecchi O; Virmani R; Stone GW
JACC Cardiovasc Interv; 2012 Jan; 5(1):12-20. PubMed ID: 22230145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
